Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin-converting enzyme inhibitors

N J Brown1, D E Vaughan

  • 1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn 37232-6602, USA. nancy.brown@mcmail.vanderbilt.edu

Circulation
|May 13, 1998
PubMed
Summary

Angiotensin-converting enzyme (ACE) inhibitors are widely used for cardiovascular and renal diseases. These drugs effectively manage hypertension, heart failure, and diabetic nephropathy by altering vasoactive substances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new species of <i>Proegernia</i> from the Namba Formation in South Australia and the early evolution and environment of Australian egerniine skinks.

Royal Society open science·2021
Same author

Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

The influences of habitat, landscape structure and climate on local distribution patterns of the nuthatch (Sitta europaea L.).

Oecologia·2017
Same author

Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations.

Clinical genetics·2015
Same author

Millennium Development Goals progress report.

Archives of disease in childhood·2015
Same author

Energy and environment. Methane leaks from North American natural gas systems.

Science (New York, N.Y.)·2014

Area of Science:

  • Pharmacology
  • Cardiology
  • Nephrology

Background:

  • ACE inhibitors are crucial in managing cardiovascular and renal conditions.
  • They modulate the balance between angiotensin II and bradykinin, affecting blood pressure and fluid balance.
  • Variations in ACE inhibitors exist regarding their chemical structure, potency, and pharmacokinetic profiles.

Purpose of the Study:

  • To review the established clinical applications of ACE inhibitors.
  • To discuss the varying properties and side effect profiles of different ACE inhibitors.
  • To highlight ongoing research into the broader applications and comparisons of ACE inhibitors.

Main Methods:

  • Literature review of ACE inhibitor pharmacology and clinical trials.
  • Analysis of drug properties including bioavailability, half-life, and tissue binding.

Related Experiment Videos

  • Examination of clinical outcomes in hypertension, heart failure, and diabetic nephropathy.

    • Main Results:

    • ACE inhibitors effectively reduce systemic vascular resistance and promote natriuresis.
    • Proven efficacy in treating hypertension, reducing mortality in heart failure and post-myocardial infarction.
    • Demonstrated ability to delay diabetic nephropathy progression.

    Conclusions:

    • ACE inhibitors are versatile drugs with significant benefits in cardiovascular and renal disease management.
    • Understanding agent-specific properties is key to optimizing treatment and managing side effects.
    • Further research is evaluating their role in specific patient populations and in comparison to newer antagonists.